The Science Behind Chronic Inflammation

Inflammation Isn't What You Think It Is

Cut your finger. It swells, turns red, feels warm. That's acute inflammation, and your immune system is doing exactly what it's built to do. White blood cells called neutrophils rush to the wound. Chemical signals called cytokines recruit reinforcements. Damaged tissue gets cleared out, and new tissue grows in. The process resolves itself.

Chronic low-grade inflammation works differently.

There's no wound. No visible swelling. No obvious trigger. Your immune system maintains a persistent, low-level activation that doesn't switch off. It's not fighting an infection or repairing an injury. It's running in the background, and the only evidence shows up on a blood panel you probably haven't had ordered.

Published research documents associations between this kind of persistent inflammation and slower tissue repair, metabolic dysfunction, hormonal disruption, cardiovascular risk, and accelerated cellular ageing. A 2017 review in Science documented how unresolved inflammatory responses impair tissue repair and drive progressive scar tissue formation when the normal resolution process fails. These associations are extensively documented across peer-reviewed literature in immunology, endocrinology, and cardiovascular medicine.

When I ran inflammatory marker assays in the laboratory, the difference between a sample with elevated CRP and one without was invisible to the naked eye. Two tubes of blood serum, sitting next to each other on the bench. Identical to look at. You can't see chronic inflammation. You can't feel your CRP rising. But your cells respond to it daily, and the downstream effects accumulate over months and years in ways that only become visible when someone actually measures them.

The distinction matters. Acute and chronic inflammation require completely different clinical thinking. One resolves on its own. The other doesn't.

The Key Inflammatory Markers and What They Measure

Your GP probably hasn't ordered most of these. Standard annual check-ups screen for acute problems, not chronic low-grade patterns. Targeted inflammatory panels exist for a reason.

CRP, or C-reactive protein, is produced by your liver in response to inflammation. Standard CRP tests catch significant elevations from acute infection or injury. High-sensitivity CRP (hs-CRP) is different. It detects the subtle, low-level elevations that characterise chronic inflammation. An hs-CRP reading above 3.0 mg/L is associated in the published literature with increased cardiovascular risk. What pushes it up: infection, tissue injury, chronic inflammatory conditions, metabolic stress, excess abdominal fat. What it doesn't tell you: which of those factors is responsible. It remains the most widely studied and most extensively validated single marker for systemic inflammation in the published literature, available through routine pathology, and ordering it adds almost nothing to the cost of a standard panel.

ESR, or erythrocyte sedimentation rate, measures something different. It tracks how quickly your red blood cells settle to the bottom of a test tube over one hour. When inflammation is present, proteins in the blood (particularly fibrinogen, a blood clotting protein) cause red blood cells to clump together and fall faster. A higher ESR signals more inflammation. It's less specific than CRP because many factors affect the sedimentation rate, but it's useful as a broad screening tool, particularly when tracked across multiple tests over time.

IL-6, or interleukin-6, is a signalling molecule (a type of cytokine) that your immune cells release during the inflammatory response. It's not routinely ordered by GPs but shows up in targeted panels. A 2002 study published in Diabetes demonstrated that IL-6 induces insulin resistance in hepatocyte (liver cell) cultures by disrupting the insulin receptor signalling pathway. That study established a molecular link between chronic inflammation and metabolic dysfunction at the cellular level, though the clinical translation of in vitro findings always warrants further investigation in human populations. When you see elevated IL-6 alongside elevated hs-CRP, the two markers together paint a more specific picture than either one alone.

Fibrinogen is a clotting factor produced by the liver. It rises with inflammation and is independently associated with cardiovascular risk in published epidemiological studies. When fibrinogen levels stay elevated, blood becomes thicker and more prone to clotting. It's measured through a standard clotting panel.

None of these markers tell you what's causing the inflammation. They tell you that inflammation is present and give you a measurable baseline. The clinical question then becomes: what's driving the elevation, and can those drivers be modified? That's where practitioner assessment, clinical history, lifestyle review, and follow-up pathology come in.

Knowing what each marker measures gives you the ability to read your own blood work with context. Not to self-diagnose. To ask better questions when your practitioner walks you through the results.

Why Chronic Inflammation Matters for Men's Health Specifically

Published research documents associations between chronic inflammation and men's health outcomes across several areas.

Tissue repair slows down. A 2017 review in Science found that persistent inflammatory signalling disrupts normal wound healing. Instead of rebuilding functional tissue, the body lays down scar tissue (fibrosis). For men recovering from injuries, chronic inflammation may slow healing and lead to poorer outcomes. Read more about injury recovery and tissue repair for the clinical picture.

Metabolic function deteriorates. Elevated inflammatory markers like hs-CRP and IL-6 are linked to insulin resistance and weight gain in published studies. The relationship appears bidirectional. Excess abdominal fat drives inflammation, and inflammation may worsen metabolic problems. Clinical weight management targets this cycle.

Hormonal balance shifts. This is where the research becomes particularly relevant for men. A 2018 review in The Aging Male documented associations between testosterone deficiency and elevated inflammatory signalling molecules, including IL-6 and TNF-alpha. Intervention studies cited in that review reported reductions in inflammatory markers following treatment of the deficiency. The literature describes this as a self-reinforcing cycle: inflammation may suppress testosterone production, and lower testosterone may reduce the body's capacity to regulate inflammation. Muscle loss and performance health are directly affected by this interplay.

Recovery capacity declines. Chronic inflammation reduces your body's ability to adapt to training and extends recovery windows between sessions. This isn't about being sore after a workout. It's about ongoing inflammation slowing the body's capacity to rebuild and adapt. A man who trains hard but recovers slowly may have inflammatory markers that standard blood work doesn't detect.

All of this is framed as association in the published research, not proven causation. Hundreds of studies show consistent directional results, and every marker discussed here can be measured directly. That makes chronic inflammation one of the most studied risk factors in men's health. But a well-documented risk factor is not the same as a proven cause. That distinction matters clinically.

What Drives Chronic Inflammation?

Chronic inflammation isn't random. The published literature identifies specific, measurable drivers.

Excess abdominal fat tops the list. Fat tissue isn't inert storage. Visceral fat actively releases inflammatory signals like IL-6 and TNF-alpha into your bloodstream. The more you carry, the higher your baseline inflammatory load. This is measurable through waist circumference and confirmed through blood markers.

Sleep deprivation runs close behind. Restricted sleep increases CRP and IL-6 levels in controlled human studies. Even a single week of poor sleep produces measurable inflammatory changes. These findings have been replicated across multiple controlled study designs with consistent results.

Chronic psychological stress contributes as well. Short-term cortisol elevation (your body's primary stress hormone) actually suppresses inflammation. But when cortisol stays elevated for months, the relationship inverts. Chronic elevation disrupts immune regulation and maintains inflammatory signalling.

Sedentary behaviour, processed food intake, environmental toxin exposure, and chronic unresolved injuries all contribute independently. The relative weight of each factor varies between individuals, and in many cases, multiple drivers operate simultaneously.

The point: chronic inflammation isn't a diagnosis. It's a measurable physiological state driven by identifiable factors. Many of those factors show up in the kind of targeted blood panel and clinical assessment a practitioner might order when investigating unexplained fatigue, poor recovery, metabolic plateaus, or weight changes.

If you want to understand what happens to your blood work and what the markers actually measure, read our breakdown of what happens to your blood work and what the markers mean.

Testing for Inflammation: Standard vs Targeted Panels

A standard GP blood test usually doesn't include hs-CRP, IL-6, or detailed inflammatory profiling. That's not a criticism of GPs. Standard annual check-ups are designed to screen for acute, common conditions: blood glucose, cholesterol, liver function, kidney function, full blood count. They're screening tools, and they do that job well.

But consider a specific scenario. You're a 38-year-old man with unexplained fatigue, a training plateau that won't shift, and a metabolic profile that doesn't match your effort in the gym. Your standard screen returns within reference ranges. The chronic inflammatory picture sits entirely outside what that panel was designed to measure.

A targeted inflammatory panel adds markers like hs-CRP, ESR, IL-6, and sometimes fibrinogen. Ordered by a practitioner assessing a specific clinical question, these markers turn an invisible physiological state into trackable data. Numbers you can compare across tests, over months.

This doesn't mean everyone needs an inflammatory panel. It means that when a practitioner suspects chronic low-grade inflammation based on your symptoms, history, and clinical presentation, targeted testing gives them the information needed to make better clinical decisions.

Screening and investigation serve different purposes. Both matter. But if standard results return within reference ranges and symptoms persist, the relevant information may sit in markers that were not included in the standard panel. Read our full breakdown of what happens to your blood work and what the markers mean for the detailed picture.